New insight on the Xq28 association with systemic sclerosis

Annals of the Rheumatic Diseases

Volumn 72, Issue 12, 2013, Pages 2032-2038

  David Carmona, F ^a   Carmen Cenit M ^a   Diaz Gallo, Lina Marcela ^a   Broen, Jasper C A ^b   Simeón, Carmen P ^c   Carreira, Patricia E ^d   Callejas Rubio, José Luis ^e   Fonollosa, Vicente ^c   López Longo, Francisco J ^f   González Gay, Miguel A ^g   Hunzelmann, Nicolas ^h   Riemekasten, Gabriela ⁱ   Witte, Torsten ^j   Kreuter, Alexander ^k   Distler, Jörg H W ^l   Madhok, Rajan ^m   Shiels, Paul ^m   Van Laar, Jacob M ⁿ   Schuerwegh, Annemie J ^o   Vonk, Madelon C ^p   Voskuyl, Alexandre E ^q   Fonseca, Carmen ^r   Denton, Christopher P ^r   Herrick, Ariane ^s   Worthington, Jane ^s   Arnett, Frank C ^t   Tan, Filemon K ^t   Assassi, Shervin ^t   Radstake, Timothy R D J ^b,p   Mayes, Maureen D ^t   Martín, Javier ^a   more..

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^g HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^h UNIVERSITY OF COLOGNE   (Germany)

ⁱ Leibniz Institute   (Germany)

^j HANNOVER MEDICAL SCHOOL   (Germany)

^k RUHR UNIVERSITY BOCHUM   (Germany)

^l UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^m GLASGOW ROYAL INFIRMARY   (United Kingdom)

ⁿ NEWCASTLE UNIVERSITY   (United Kingdom)

^o LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^p RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^q VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^r ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^s UNIVERSITY OF MANCHESTER   (United Kingdom)

^t UNIVERSITY OF TEXAS   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; METHYL CPG BINDING PROTEIN 2;

ARTICLE; CHROMOSOME XQ; CHROMOSOME XQ28; CONTROLLED STUDY; DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GERMANY; HAPLOTYPE; HUMAN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1 GENE; LUNG FIBROSIS; MAJOR CLINICAL STUDY; METHYL CPG BINDING PROTEIN 2 GENE; NETHERLANDS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; SYSTEMIC SCLEROSIS; UNITED KINGDOM; UNITED STATES;

AUTOIMMUNE DISEASES; GENE POLYMORPHISM; SYSTEMIC SCLEROSIS;

CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, X; FEMALE; GENE FREQUENCY; GENETIC DISEASES, X-LINKED; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LINKAGE DISEQUILIBRIUM; METHYL-CPG-BINDING PROTEIN 2; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY FIBROSIS; SCLERODERMA, DIFFUSE; SCLERODERMA, SYSTEMIC;

EID: 84887451383     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202742     Document Type: Article

References (44)

1. Cho JH, Gregersen PK. Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 2011;365:1612-23.
2. Cotsapas C, Voight BF, Rossin E, et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet 2011;7:e1002254.
3. Zenewicz LA, Abraham C, Flavell RA, et al. Unraveling the genetics of autoimmunity. Cell 2010;140:791-7.
4. Zhernakova A, Van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 2009;10:43-55.
5. Harley JB, Alarcon-Riquelme ME, Criswell LA, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008;40:204-10.
6. Martin JE, Bossini-Castillo L, Martin J. Unraveling the genetic component of systemic sclerosis. Hum Genet 2012;131:1023-37.
7. Libert C, Dejager L, Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol 2010;10:594-604.
8. Invernizzi P, Pasini S, Selmi C, et al. Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun 2009;33:12-16.
9. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009;360:1989-2003.
10. Dieude P, Bouaziz M, Guedj M, et al. Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype. Arthritis Rheum 2011;63:3979-87.
11. Jacob CO, Zhu J, Armstrong DL, et al. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci USA 2009;106:6256-61.
12. Netea MG, Wijmenga C, O'Neill LA. Genetic variation in Toll-like receptors and disease susceptibility. Nat Immunol 2012;13:535-42.
13. Rao N, Nguyen S, Ngo K, et al. A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling. Mol Cell Biol 2005;25:6521-32.
14. Sawalha AH, Webb R, Han S, et al. Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS One 2008;3:e1727.
15. Webb R, Wren JD, Jeffries M, et al. Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. Arthritis Rheum 2009;60:1076-84.
16. Sawalha AH. Xq28 and lupus: IRAK1 or MECP2? Proc Natl Acad Sci USA 2009;106:E62; author reply E63.
17. Le Roy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
18. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
19. Skol AD, Scott LJ, Abecasis GR, et al. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006;38:209-13.
20. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75.
21. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 1995;57:289-300.
22. Cobb BL, Fei Y, Jonsson R, et al. Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjogren's syndrome. Ann Rheum Dis 2010;69:1731-2.
23. Brooks WH, Le Dantec C, Pers JO, et al. Epigenetics and autoimmunity. J Autoimmun 2010;34:J207-19.
24. Sawalha AH, Jeffries M, Webb R, et al. Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun 2008;9:368-78.
25. Sawalha AH, Jeffries M. Defective DNA methylation and CD70 overexpression in CD4+ T cells in MRL/lpr lupus-prone mice. Eur J Immunol 2007;37:1407-13.
26. Pan Y, Sawalha AH. Epigenetic regulation and the pathogenesis of systemic lupus erythematosus. Transl Res 2009;153:4-10.
27. Urdinguio RG, Lopez-Serra L, Lopez-Nieva P, et al. Mecp2-null mice provide new neuronal targets for Rett syndrome. PLoS One 2008;3:e3669.
28. Chahrour M, Jung SY, Shaw C, et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008;320:1224-9.
29. Urdinguio RG, Fernandez AF, Lopez-Nieva P, et al. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics 2010;5:656-63.
30. Kaufman KM, Zhao J, Kelly JA, et al. Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups. Ann Rheum Dis 2013;72:437-44.
31. Suarez-Gestal M, Calaza M, Endreffy E, et al. Replication of recently identified systemic lupus erythematosus genetic associations: a case-control study. Arthritis Res Ther 2009;11:R69.
32. Hudson M, Rojas-Villarraga A, Coral-Alvarado P, etal. Polyautoimmunity and familial autoimmunity in systemic sclerosis. J Autoimmun 2008;31:156-9.
33. Avouac J, Airo P, Dieude P, etal. Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients. J Rheumatol 2010;37:608-14.
34. Korman BD, Alba MI, Le JM, et al. Variant form of STAT4 is associated with primary Sjogren's syndrome. Genes Immun 2008;9:267-70.
35. Nguyen CQ, Peck AB. Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease. Ocul Surf 2009;7:11-27.
36. Assassi S, Mayes MD, Arnett FC, et al. Systemic sclerosis and lupus: points in an interferon-mediated continuum. Arthritis Rheum 2010;62:589-98.
37. Chow JC, Brown CJ. Forming facultative heterochromatin: silencing of an X chromosome in mammalian females. Cell Mol Life Sci 2003;60:2586-03.
38. Doffinger R, Smahi A, Bessia C, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 2001;27:277-85.
39. Noguchi M, Yi H, Rosenblatt HM, etal. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993;73:147-57.
40. Cerutti A, Puga I, Cols M. Innate control of B cell responses. Trends Immunol 2011;32:202-11.
41. Zheng Y, Rudensky AY. Foxp3 in control of the regulatory T cell lineage. Nat Immunol 2007;8:457-62.
42. Valentini G, Romano MF, Naclerio C, et al. Increased expression of CD40 ligand in activated CD4+ T lymphocytes of systemic sclerosis patients. J Autoimmun 2000;15:61-6.
43. Lian X, Xiao R, Hu X, et al. DNA demethylation of CD40L in CD4 (+) T-cells from women with systemic sclerosis-A possible explanation for female susceptibility. Arthritis Rheum 2012;64:2338-45.
44. Carmona FD, Simeon CP, Beretta L, et al. Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis. Ann Rheum Dis 2011;70:2050-2.